{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=PF-04937319", "query": { "intervention": "PF-04937319" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 7, "total_pages": 1, "next_page_url": null, "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-09-11T10:16:36.837Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT01475461", "title": "Phase 2 Study To Evaluate Safety And Efficacy Of Investigational Drug - PF04937319 In Patients With Type 2 Diabetes", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Type 2 Diabetes Mellitus" ], "interventions": [ { "name": "Placebo", "type": "DRUG" }, { "name": "PF-04937319 - 3mg", "type": "DRUG" }, { "name": "PF-04937319 - 20mg", "type": "DRUG" }, { "name": "PF-04937319 - 50mg", "type": "DRUG" }, { "name": "PF-04937319 - 100mg", "type": "DRUG" }, { "name": "Sitagliptin - 100mg", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 345, "start_date": "2011-11", "completion_date": "2013-01", "has_results": true, "last_update_posted_date": "2017-01-31", "last_synced_at": "2026-09-11T10:16:36.837Z", "location_count": 24, "location_summary": "Anaheim, California • Los Angeles, California • Spring Valley, California + 18 more", "locations": [ { "city": "Anaheim", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Spring Valley", "state": "California" }, { "city": "Belleview", "state": "Florida" }, { "city": "Miami", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT01475461" }, { "nct_id": "NCT01517373", "title": "Study To Understand Efficacy And Safety Of Investigational Agent (PF-04937319) Compared To Approved Agent (Glimepiride) In Patients With Diabetes On Metformin", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Diabetes Mellitus, Type 2" ], "interventions": [ { "name": "Placebo", "type": "DRUG" }, { "name": "PF-04937319 10 mg", "type": "DRUG" }, { "name": "PF-04937319 50 mg", "type": "DRUG" }, { "name": "PF-04937319 100 mg", "type": "DRUG" }, { "name": "Glimepiride", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 304, "start_date": "2012-02", "completion_date": "2013-01", "has_results": true, "last_update_posted_date": "2017-01-31", "last_synced_at": "2026-09-11T10:16:36.837Z", "location_count": 23, "location_summary": "Roseville, California • San Diego, California • Walnut Creek, California + 17 more", "locations": [ { "city": "Roseville", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "Walnut Creek", "state": "California" }, { "city": "Bradenton", "state": "Florida" }, { "city": "Pembroke Pines", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT01517373" }, { "nct_id": "NCT01933672", "title": "Study Of Two Dosing Regimens Of PF-04937319 Compared To An Approved Agent (Sitagliptin) In Patients With Type 2 Diabetes", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Type 2 Diabetes Mellitus" ], "interventions": [ { "name": "PF-04937319 once-daily", "type": "DRUG" }, { "name": "PF-04937319 split-dose", "type": "DRUG" }, { "name": "Sitagliptin once-daily", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 33, "start_date": "2013-10", "completion_date": "2014-03", "has_results": true, "last_update_posted_date": "2016-09-27", "last_synced_at": "2026-09-11T10:16:36.837Z", "location_count": 8, "location_summary": "DeLand, Florida • South Miami, Florida • High Point, North Carolina + 3 more", "locations": [ { "city": "DeLand", "state": "Florida" }, { "city": "South Miami", "state": "Florida" }, { "city": "South Miami", "state": "Florida" }, { "city": "High Point", "state": "North Carolina" }, { "city": "Cincinnati", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT01933672" }, { "nct_id": "NCT02206607", "title": "Study To Compare Single Dose Of Three Modified Release Formulations Of PF-04937319 With Immediate Release Material-Sparing-Tablet (IR MST) Formulation Previously Studied In Adults With Type 2 Diabetes Mellitus.", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Type 2 Diabetes Mellitus" ], "interventions": [ { "name": "PF-04937319 IR MST", "type": "DRUG" }, { "name": "PF-04937319 MR 1", "type": "DRUG" }, { "name": "PF-04937319 MR 2", "type": "DRUG" }, { "name": "PF-04937319 MR 3", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 39, "start_date": "2014-09", "completion_date": "2015-01", "has_results": true, "last_update_posted_date": "2016-03-04", "last_synced_at": "2026-09-11T10:16:36.837Z", "location_count": 2, "location_summary": "High Point, North Carolina • San Antonio, Texas", "locations": [ { "city": "High Point", "state": "North Carolina" }, { "city": "San Antonio", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT02206607" }, { "nct_id": "NCT01044537", "title": "A Trial To Assess The Safety, Tolerability, Pharmacokinetics, And Pharmacodynamics Of Single Doses Of PF-04937319 In Subjects With Type 2 Diabetes Mellitus", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Type 2 Diabetes Mellitus" ], "interventions": [ { "name": "Placebo", "type": "DRUG" }, { "name": "PF-04937319", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 50, "start_date": "2010-02", "completion_date": "2010-05", "has_results": true, "last_update_posted_date": "2017-03-10", "last_synced_at": "2026-09-11T10:16:36.837Z", "location_count": 3, "location_summary": "Phoenix, Arizona • Cypress, California • Miami, Florida", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Cypress", "state": "California" }, { "city": "Miami", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT01044537" }, { "nct_id": "NCT01272804", "title": "Multiple Dose Study Of PF-04937319 In Patients With Type 2 Diabetes", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Diabetes Mellitus, Type 2", "NIDDM" ], "interventions": [ { "name": "PF-04937319", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 61, "start_date": "2011-02", "completion_date": "2011-07", "has_results": true, "last_update_posted_date": "2017-02-01", "last_synced_at": "2026-09-11T10:16:36.837Z", "location_count": 4, "location_summary": "Miami, Florida • South Miami, Florida • Cincinnati, Ohio", "locations": [ { "city": "Miami", "state": "Florida" }, { "city": "South Miami", "state": "Florida" }, { "city": "South Miami", "state": "Florida" }, { "city": "Cincinnati", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT01272804" }, { "nct_id": "NCT01468714", "title": "A Study To Estimate The Effect Of Ketoconazole On The Pharmacokinetics Of Pf-04937319 In Healthy Subjects", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Human Volunteers" ], "interventions": [ { "name": "PF-04937319 / ketoconazole", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 10, "start_date": "2011-10", "completion_date": "2011-10", "has_results": false, "last_update_posted_date": "2011-11-16", "last_synced_at": "2026-09-11T10:16:36.837Z", "location_count": 1, "location_summary": "New Haven, Connecticut", "locations": [ { "city": "New Haven", "state": "Connecticut" } ], "official_url": "https://clinicaltrials.gov/study/NCT01468714" } ] }